ID   ABCD1_HUMAN             Reviewed;         745 AA.
AC   P33897; Q6GTZ2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 2.
DT   10-MAY-2017, entry version 197.
DE   RecName: Full=ATP-binding cassette sub-family D member 1;
DE   AltName: Full=Adrenoleukodystrophy protein;
DE            Short=ALDP;
GN   Name=ABCD1; Synonyms=ALD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8441467; DOI=10.1038/361726a0;
RA   Mosser J., Douar A.-M., Sarde C.-O., Kioschis P., Feil R., Moser H.,
RA   Poustka A.-M., Mandel J.-L., Aubourg P.;
RT   "Putative X-linked adrenoleukodystrophy gene shares unexpected
RT   homology with ABC transporters.";
RL   Nature 361:726-730(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBUNIT, AND CHARACTERIZATION OF VARIANTS ALD HIS-389; GLN-401;
RP   ARG-484 AND GLN-591.
RX   PubMed=10551832; DOI=10.1074/jbc.274.46.32738;
RA   Liu L.X., Janvier K., Berteaux-Lecellier V., Cartier N., Benarous R.,
RA   Aubourg P.;
RT   "Homo- and heterodimerization of peroxisomal ATP-binding cassette
RT   half-transporters.";
RL   J. Biol. Chem. 274:32738-32743(1999).
RN   [5]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANTS ALD SER-512 AND LEU-606.
RX   PubMed=11248239; DOI=10.1016/S0014-5793(01)02235-9;
RA   Roerig P., Mayerhofer P., Holzinger A., Gaertner J.;
RT   "Characterization and functional analysis of the nucleotide binding
RT   fold in human peroxisomal ATP binding cassette transporters.";
RL   FEBS Lett. 492:66-72(2001).
RN   [6]
RP   REVIEW.
RX   PubMed=8507690; DOI=10.1016/0300-9084(93)90089-B;
RA   Aubourg P., Mosser J., Douar A.-M., Sarde C.-O., Lopez J.,
RA   Mandel J.-L.;
RT   "Adrenoleukodystrophy gene: unexpected homology to a protein involved
RT   in peroxisome biogenesis.";
RL   Biochimie 75:293-302(1993).
RN   [7]
RP   INTERACTION WITH PEX19.
RC   TISSUE=Brain;
RX   PubMed=10777694; DOI=10.1006/bbrc.2000.2572;
RA   Gloeckner C.J., Mayerhofer P.U., Landgraf P., Muntau A.C.,
RA   Holzinger A., Gerber J.-K., Kammerer S., Adamski J., Roscher A.A.;
RT   "Human adrenoleukodystrophy protein and related peroxisomal ABC
RT   transporters interact with the peroxisomal assembly protein PEX19p.";
RL   Biochem. Biophys. Res. Commun. 271:144-150(2000).
RN   [8]
RP   INTERACTION WITH PEX19.
RX   PubMed=10704444; DOI=10.1083/jcb.148.5.931;
RA   Sacksteder K.A., Jones J.M., South S.T., Li X., Liu Y., Gould S.J.;
RT   "PEX19 binds multiple peroxisomal membrane proteins, is predominantly
RT   cytoplasmic, and is required for peroxisome membrane synthesis.";
RL   J. Cell Biol. 148:931-944(2000).
RN   [9]
RP   REVIEW ON VARIANTS.
RX   PubMed=9195223;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:6<500::AID-HUMU2>3.0.CO;2-5;
RA   Dodd A., Rowland S.A., Hawkes S.L.J., Kennedy M.A., Love D.R.;
RT   "Mutations in the adrenoleukodystrophy gene.";
RL   Hum. Mutat. 9:500-511(1997).
RN   [10]
RP   REVIEW ON VARIANTS.
RX   PubMed=11748843; DOI=10.1002/humu.1227;
RA   Kemp S., Pujol A., Waterham H.R., van Geel B.M., Boehm C.D.,
RA   Raymond G.V., Cutting G.R., Wanders R.J.A., Moser H.W.;
RT   "ABCD1 mutations and the X-linked adrenoleukodystrophy mutation
RT   database: role in diagnosis and clinical correlations.";
RL   Hum. Mutat. 18:499-515(2001).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-733, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-733, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANT ALD LYS-291.
RX   PubMed=7904210; DOI=10.1093/hmg/2.11.1949;
RA   Cartier N., Sarde C.-O., Douar A.-M., Mosser J., Mandel J.-L.,
RA   Aubourg P.;
RT   "Abnormal messenger RNA expression and a missense mutation in patients
RT   with X-linked adrenoleukodystrophy.";
RL   Hum. Mol. Genet. 2:1949-1951(1993).
RN   [17]
RP   VARIANTS ALD SER-148; ASP-174; ARG-266; GLN-401; TRP-418 AND PHE-515.
RX   PubMed=7849723; DOI=10.1093/hmg/3.10.1903;
RA   Fuchs S., Sarde C.-O., Wedemann H., Schwinger E., Mandel J.-L.,
RA   Gal A.;
RT   "Missense mutations are frequent in the gene for X-chromosomal
RT   adrenoleukodystrophy (ALD).";
RL   Hum. Mol. Genet. 3:1903-1905(1994).
RN   [18]
RP   VARIANTS ALD TRP-518; LEU-606; CYS-617 AND HIS-617.
RX   PubMed=8040304; DOI=10.1172/JCI117363;
RA   Fanen P., Guidoux S., Sarde C.-O., Mandel J.-L., Goossens M.,
RA   Aubourg P.;
RT   "Identification of mutations in the putative ATP-binding domain of the
RT   adrenoleukodystrophy gene.";
RL   J. Clin. Invest. 94:516-520(1994).
RN   [19]
RP   VARIANTS ALD.
RX   PubMed=7825602;
RA   Ligtenberg M.J.L., Kemp S., Sarde C.-O., van Geel B.M., Kleijer W.J.,
RA   Barth P.G., Mandel J.-L., van Oost B.A., Bolhuis P.A.;
RT   "Spectrum of mutations in the gene encoding the adrenoleukodystrophy
RT   protein.";
RL   Am. J. Hum. Genet. 56:44-50(1995).
RN   [20]
RP   VARIANTS ALD HIS-104; GLU-178; GLY-528 DEL AND LEU-560.
RX   PubMed=7717396;
RA   Braun A., Ambach H., Kammerer S., Rolinski B., Stoeckler S., Rabl W.,
RA   Gaertner J., Zierz S., Roscher A.A.;
RT   "Mutations in the gene for X-linked adrenoleukodystrophy in patients
RT   with different clinical phenotypes.";
RL   Am. J. Hum. Genet. 56:854-861(1995).
RN   [21]
RP   VARIANTS ALD.
RX   PubMed=7581394; DOI=10.1002/humu.1380060203;
RA   Kok F., Neumann S., Sarde C.-O., Zheng S., Wu K.-H., Wei H.-M.,
RA   Bergin J., Watkins P.A., Gould S., Sack G., Moser H., Mandel J.-L.,
RA   Smith K.D.;
RT   "Mutational analysis of patients with X-linked adrenoleukodystrophy.";
RL   Hum. Mutat. 6:104-115(1995).
RN   [22]
RP   VARIANTS ALD.
RX   PubMed=8651290;
RA   Feigenbaum V., Lombard-Platet G., Guidoux S., Sarde C.-O.,
RA   Mandel J.-L., Aubourg P.;
RT   "Mutational and protein analysis of patients and heterozygous women
RT   with X-linked adrenoleukodystrophy.";
RL   Am. J. Hum. Genet. 58:1135-1144(1996).
RN   [23]
RP   VARIANTS ALD PRO-107; ASP-174; MET-254; GLY-389; GLN-401; TRP-418;
RP   LYS-609; CYS-617 AND GLY-617.
RX   PubMed=8566952; DOI=10.1007/BF02265264;
RA   Krasemann E.W., Meier V., Korenke G.C., Hunneman D.H., Hanefeld F.;
RT   "Identification of mutations in the ALD-gene of 20 families with
RT   adrenoleukodystrophy/adrenomyeloneuropathy.";
RL   Hum. Genet. 97:194-197(1996).
RN   [24]
RP   VARIANT ALD ARG-679.
RX   PubMed=9452087;
RA   Korenke G.C., Krasemann E., Meier V., Beuche W., Hunneman D.H.,
RA   Hanefeld F.;
RT   "First missense mutation (W679R) in exon 10 of the
RT   adrenoleukodystrophy gene in siblings with adrenomyeloneuropathy.";
RL   Hum. Mutat. Suppl. 1:S204-S206(1998).
RN   [25]
RP   VARIANTS ALD PRO-105; SER-143; SER-148; PRO-190; ASP-298; SER-529 AND
RP   TYR-638.
RX   PubMed=10480364; DOI=10.1007/s004399900090;
RA   Wichers M., Kohler W., Brennemann W., Boese V., Sokolowski P.,
RA   Bidlingmaier F., Ludwig M.;
RT   "X-linked adrenomyeloneuropathy associated with 14 novel ALD-gene
RT   mutations: no correlation between type of mutation and age of onset.";
RL   Hum. Genet. 105:116-119(1999).
RN   [26]
RP   VARIANTS ALD LEU-108 AND SER-143.
RX   PubMed=10369742; DOI=10.1006/mcpr.1999.0232;
RA   Perusi C., Gomez-Lira M., Mottes M., Pignatti P.F., Bertini E.,
RA   Cappa M., Vigliani M.C., Schiffer D., Rizzuto N., Salviati A.;
RT   "Two novel missense mutations causing adrenoleukodystrophy in Italian
RT   patients.";
RL   Mol. Cell. Probes 13:179-182(1999).
RN   [27]
RP   VARIANTS ALD ARG-103; ARG-116; SER-152; CYS-174; TRP-189; THR-218;
RP   PRO-229; ASP-298; GLN-401; TRP-401; TRP-418; LEU-543; HIS-554;
RP   VAL-616; ARG-633 AND PRO-646.
RX   PubMed=10737980;
RX   DOI=10.1002/(SICI)1098-1004(200004)15:4<348::AID-HUMU7>3.0.CO;2-N;
RA   Lachtermacher M.B., Seuanez H.N., Moser A.B., Moser H.W., Smith K.D.;
RT   "Determination of 30 X-linked adrenoleukodystrophy mutations,
RT   including 15 not previously described.";
RL   Hum. Mutat. 15:348-353(2000).
RN   [28]
RP   VARIANTS ALD GLN-401; TRP-418; LEU-543 AND ARG-556.
RX   PubMed=10980539;
RX   DOI=10.1002/1098-1004(200009)16:3<271::AID-HUMU15>3.0.CO;2-D;
RA   Lira M.G., Mottes M., Pignatti P.F., Medica I., Uziel G., Cappa M.,
RA   Bertini E., Rizzuto N., Salviati A.;
RT   "Detection of mutations in the ALD gene (ABCD1) in seven Italian
RT   families: description of four novel mutations.";
RL   Hum. Mutat. 16:271-271(2000).
RN   [29]
RP   VARIANTS ALD LEU-98; ASP-99; GLU-217; GLN-518; ASP-608; ILE-633 AND
RP   PRO-660, AND VARIANT THR-13.
RX   PubMed=11438993; DOI=10.1002/humu.1149;
RA   Dvorakova L., Storkanova G., Unterrainer G., Hujova J., Kmoch S.,
RA   Zeman J., Hrebicek M., Berger J.;
RT   "Eight novel ABCD1 gene mutations and three polymorphisms in patients
RT   with X-linked adrenoleukodystrophy: the first polymorphism causing an
RT   amino acid exchange.";
RL   Hum. Mutat. 18:52-60(2001).
RN   [30]
RP   VARIANT ALD VAL-GLY-GLN-300 INS.
RX   PubMed=11810273; DOI=10.1007/s00439-001-0632-z;
RA   Guimaraes C.P., Lemos M., Menezes I., Coelho T., Sa-Miranda C.,
RA   Azevedo J.E.;
RT   "Characterisation of two mutations in the ABCD1 gene leading to low
RT   levels of normal ALDP.";
RL   Hum. Genet. 109:616-622(2001).
RN   [31]
RP   INVOLVEMENT IN CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME.
RX   PubMed=11992258; DOI=10.1086/340849;
RA   Corzo D., Gibson W., Johnson K., Mitchell G., LePage G., Cox G.F.,
RA   Casey R., Zeiss C., Tyson H., Cutting G.R., Raymond G.V., Smith K.D.,
RA   Watkins P.A., Moser A.B., Moser H.W., Steinberg S.J.;
RT   "Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1)
RT   and DXS1357E: a novel neonatal phenotype similar to peroxisomal
RT   biogenesis disorders.";
RL   Am. J. Hum. Genet. 70:1520-1531(2002).
RN   [32]
RP   VARIANTS ALD TRP-88; CYS-152; CYS-181; SER-343; PRO-503; ARG-514 AND
RP   HIS-554.
RX   PubMed=15643618; DOI=10.1002/humu.9303;
RA   Montagna G., Di Biase A., Cappa M., Melone M.A.B., Piantadosi C.,
RA   Colabianchi D., Patrono C., Attori L., Cannelli N., Cotrufo R.,
RA   Salvati S., Santorelli F.M.;
RT   "Identification of seven novel mutations in ABCD1 by a DHPLC-based
RT   assay in Italian patients with X-linked adrenoleukodystrophy.";
RL   Hum. Mutat. 25:222-222(2005).
RN   [33]
RP   VARIANTS ALD GLN-401; PRO-516; LEU-560; PRO-606 AND GLN-660.
RX   PubMed=21889498; DOI=10.1016/j.cca.2011.08.026;
RA   Shukla P., Gupta N., Gulati S., Ghosh M., Vasisht S., Sharma R.,
RA   Gupta A.K., Kalra V., Kabra M.;
RT   "Molecular analysis of ABCD1 gene in Indian patients with X-linked
RT   adrenoleukodystrophy.";
RL   Clin. Chim. Acta 412:2289-2295(2011).
RN   [34]
RP   VARIANTS ALD LEU-139 DEL; ARG-198; ARG-266; GLU-266; TRP-401; GLN-518;
RP   PHE-523; CYS-540; LEU-560; PRO-606; HIS-617; THR-626; PRO-632;
RP   ARG-633; LYS-640 AND ASP-677.
RX   PubMed=21700483; DOI=10.1016/j.ymgme.2011.05.016;
RA   Wang Y., Busin R., Reeves C., Bezman L., Raymond G., Toomer C.J.,
RA   Watkins P.A., Snowden A., Moser A., Naidu S., Bibat G., Hewson S.,
RA   Tam K., Clarke J.T., Charnas L., Stetten G., Karczeski B., Cutting G.,
RA   Steinberg S.;
RT   "X-linked adrenoleukodystrophy: ABCD1 de novo mutations and
RT   mosaicism.";
RL   Mol. Genet. Metab. 104:160-166(2011).
RN   [35]
RP   VARIANT ALD ASP-95.
RX   PubMed=23651979; DOI=10.1159/000346680;
RA   Kallabi F., Hadj Salem I., Ben Salah G., Ben Turkia H.,
RA   Ben Chehida A., Tebib N., Fakhfakh F., Kamoun H.;
RT   "Molecular characterization of X-linked adrenoleukodystrophy in a
RT   Tunisian family: identification of a novel missense mutation in the
RT   ABCD1 gene.";
RL   Neurodegener. Dis. 12:207-211(2013).
RN   [36]
RP   VARIANT ALD PRO-316.
RX   PubMed=26686776; DOI=10.1016/j.cca.2015.12.014;
RA   Kallabi F., Ellouz E., Tabebi M., Ben Salah G., Kaabechi N.,
RA   Keskes L., Triki C., Kamoun H.;
RT   "Phenotypic variability in a Tunisian family with X-linked
RT   adrenoleukodystrophy caused by the p.Gln316Pro novel mutation.";
RL   Clin. Chim. Acta 453:141-146(2015).
CC   -!- FUNCTION: Probable transporter. The nucleotide-binding fold acts
CC       as an ATP-binding subunit with ATPase activity.
CC       {ECO:0000269|PubMed:11248239}.
CC   -!- SUBUNIT: Can form homodimers and heterodimers with ABCD2/ALDR and
CC       ABCD3/PMP70. Dimerization is necessary to form an active
CC       transporter. Interacts with PEX19. {ECO:0000269|PubMed:10551832,
CC       ECO:0000269|PubMed:10704444, ECO:0000269|PubMed:10777694}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-81045, EBI-81045;
CC       P48410:Abcd1 (xeno); NbExp=2; IntAct=EBI-81045, EBI-81118;
CC       P28288:ABCD3; NbExp=2; IntAct=EBI-81045, EBI-80992;
CC       P40855:PEX19; NbExp=3; IntAct=EBI-81045, EBI-594747;
CC   -!- SUBCELLULAR LOCATION: Peroxisome membrane; Multi-pass membrane
CC       protein.
CC   -!- DISEASE: Adrenoleukodystrophy (ALD) [MIM:300100]: A peroxisomal
CC       metabolic disorder characterized by progressive multifocal
CC       demyelination of the central nervous system and by peripheral
CC       adrenal insufficiency (Addison disease). It results in mental
CC       deterioration, corticospinal tract dysfunction, and cortical
CC       blindness. Different clinical manifestations exist like: cerebral
CC       childhood ALD (CALD), adult cerebral ALD (ACALD),
CC       adrenomyeloneuropathy (AMN) and 'Addison disease only' (ADO)
CC       phenotype. {ECO:0000269|PubMed:10369742,
CC       ECO:0000269|PubMed:10480364, ECO:0000269|PubMed:10551832,
CC       ECO:0000269|PubMed:10737980, ECO:0000269|PubMed:10980539,
CC       ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:11438993,
CC       ECO:0000269|PubMed:11810273, ECO:0000269|PubMed:15643618,
CC       ECO:0000269|PubMed:21700483, ECO:0000269|PubMed:21889498,
CC       ECO:0000269|PubMed:23651979, ECO:0000269|PubMed:26686776,
CC       ECO:0000269|PubMed:7581394, ECO:0000269|PubMed:7717396,
CC       ECO:0000269|PubMed:7825602, ECO:0000269|PubMed:7849723,
CC       ECO:0000269|PubMed:7904210, ECO:0000269|PubMed:8040304,
CC       ECO:0000269|PubMed:8566952, ECO:0000269|PubMed:8651290,
CC       ECO:0000269|PubMed:9452087}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=The promoter region of ABCD1 is deleted in the
CC       chromosome Xq28 deletion syndrome which involves ABCD1 and the
CC       neighboring gene BCAP31. {ECO:0000269|PubMed:11992258}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCD
CC       family. Peroxisomal fatty acyl CoA transporter (TC 3.A.1.203)
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=X-ALD gene mutation database;
CC       URL="http://www.x-ald.nl/";
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=P33897";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z21876; CAA79922.1; -; mRNA.
DR   EMBL; Z31348; CAA83230.1; -; Genomic_DNA.
DR   EMBL; Z31006; CAA83230.1; JOINED; Genomic_DNA.
DR   EMBL; Z31007; CAA83230.1; JOINED; Genomic_DNA.
DR   EMBL; Z31008; CAA83230.1; JOINED; Genomic_DNA.
DR   EMBL; Z31009; CAA83230.1; JOINED; Genomic_DNA.
DR   EMBL; Z31010; CAA83230.1; JOINED; Genomic_DNA.
DR   EMBL; U52111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015541; AAH15541.1; -; mRNA.
DR   EMBL; BC025358; AAH25358.1; -; mRNA.
DR   CCDS; CCDS14728.1; -.
DR   PIR; G02500; G02500.
DR   RefSeq; NP_000024.2; NM_000033.3.
DR   UniGene; Hs.159546; -.
DR   ProteinModelPortal; P33897; -.
DR   BioGrid; 106717; 31.
DR   IntAct; P33897; 16.
DR   STRING; 9606.ENSP00000218104; -.
DR   SwissLipids; SLP:000000458; -.
DR   TCDB; 3.A.1.203.3; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; P33897; -.
DR   PhosphoSitePlus; P33897; -.
DR   BioMuta; ABCD1; -.
DR   DMDM; 67476960; -.
DR   EPD; P33897; -.
DR   MaxQB; P33897; -.
DR   PaxDb; P33897; -.
DR   PeptideAtlas; P33897; -.
DR   PRIDE; P33897; -.
DR   DNASU; 215; -.
DR   Ensembl; ENST00000218104; ENSP00000218104; ENSG00000101986.
DR   GeneID; 215; -.
DR   KEGG; hsa:215; -.
DR   UCSC; uc004fif.2; human.
DR   CTD; 215; -.
DR   DisGeNET; 215; -.
DR   GeneCards; ABCD1; -.
DR   GeneReviews; ABCD1; -.
DR   HGNC; HGNC:61; ABCD1.
DR   MalaCards; ABCD1; -.
DR   MIM; 300100; phenotype.
DR   MIM; 300371; gene.
DR   neXtProt; NX_P33897; -.
DR   OpenTargets; ENSG00000101986; -.
DR   Orphanet; 139399; Adrenomyeloneuropathy.
DR   Orphanet; 369942; CADDS.
DR   Orphanet; 139396; X-linked cerebral adrenoleukodystrophy.
DR   PharmGKB; PA24396; -.
DR   eggNOG; KOG0064; Eukaryota.
DR   eggNOG; COG4178; LUCA.
DR   GeneTree; ENSGT00390000003950; -.
DR   HOGENOM; HOG000206081; -.
DR   HOVERGEN; HBG050438; -.
DR   InParanoid; P33897; -.
DR   KO; K05675; -.
DR   OMA; PRVLCRE; -.
DR   OrthoDB; EOG091G04M1; -.
DR   PhylomeDB; P33897; -.
DR   TreeFam; TF105205; -.
DR   BRENDA; 3.6.3.47; 2681.
DR   Reactome; R-HSA-1369062; ABC transporters in lipid homeostasis.
DR   Reactome; R-HSA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-HSA-390247; Beta-oxidation of very long chain fatty acids.
DR   GeneWiki; ABCD1; -.
DR   GenomeRNAi; 215; -.
DR   PRO; PR:P33897; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101986; -.
DR   CleanEx; HS_ABCD1; -.
DR   ExpressionAtlas; P33897; baseline and differential.
DR   Genevisible; P33897; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005779; C:integral component of peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; NAS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005324; F:long-chain fatty acid transporter activity; EXP:Reactome.
DR   GO; GO:0005325; F:peroxisomal fatty-acyl-CoA transporter activity; IGI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; NAS:UniProtKB.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome.
DR   GO; GO:0043651; P:linoleic acid metabolic process; TAS:Reactome.
DR   GO; GO:0042758; P:long-chain fatty acid catabolic process; IGI:UniProtKB.
DR   GO; GO:0015910; P:peroxisomal long-chain fatty acid import; IGI:UniProtKB.
DR   GO; GO:0015919; P:peroxisomal membrane transport; NAS:UniProtKB.
DR   GO; GO:0007031; P:peroxisome organization; IDA:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0042760; P:very long-chain fatty acid catabolic process; IDA:UniProtKB.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR031237; ALDP.
DR   InterPro; IPR005283; FA_transporter.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11384:SF42; PTHR11384:SF42; 1.
DR   Pfam; PF06472; ABC_membrane_2; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF90123; SSF90123; 1.
DR   TIGRFAMs; TIGR00954; 3a01203; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Disease mutation; Glycoprotein;
KW   Membrane; Nucleotide-binding; Peroxisome; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    745       ATP-binding cassette sub-family D member
FT                                1.
FT                                /FTId=PRO_0000093304.
FT   TRANSMEM     92    112       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    131    151       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    333    353       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    473    493       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   DOMAIN       94    386       ABC transmembrane type-1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      474    700       ABC transporter. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     507    514       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   REGION       67    186       Interaction with PEX19.
FT   MOD_RES     733    733       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      13     13       N -> T (very rare polymorphism; does not
FT                                affect ALDP function; dbSNP:rs183021839).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_013340.
FT   VARIANT      88     88       C -> W (in ALD).
FT                                {ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_023004.
FT   VARIANT      90     90       E -> K (in ALD).
FT                                /FTId=VAR_009349.
FT   VARIANT      95     95       A -> D (in ALD).
FT                                {ECO:0000269|PubMed:23651979}.
FT                                /FTId=VAR_075284.
FT   VARIANT      98     98       S -> L (in ALD; CALD type).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_000024.
FT   VARIANT      99     99       A -> D (in ALD; AMN-type).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_013341.
FT   VARIANT     103    103       S -> R (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009350.
FT   VARIANT     104    104       R -> C (in ALD).
FT                                /FTId=VAR_000025.
FT   VARIANT     104    104       R -> H (in ALD; ADO-type).
FT                                {ECO:0000269|PubMed:7717396}.
FT                                /FTId=VAR_000026.
FT   VARIANT     105    105       T -> I (in ALD; ADO-type).
FT                                /FTId=VAR_000027.
FT   VARIANT     105    105       T -> P (in ALD).
FT                                {ECO:0000269|PubMed:10480364}.
FT                                /FTId=VAR_009351.
FT   VARIANT     107    107       L -> P (in ALD; ALD/AMN/ADO-types and
FT                                asymptomatic).
FT                                {ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000028.
FT   VARIANT     108    108       S -> L (in ALD).
FT                                {ECO:0000269|PubMed:10369742}.
FT                                /FTId=VAR_009352.
FT   VARIANT     108    108       S -> W (in ALD; CALD and AMN-types).
FT                                /FTId=VAR_000029.
FT   VARIANT     113    113       R -> C (in ALD).
FT                                /FTId=VAR_009353.
FT   VARIANT     113    113       R -> P (in ALD).
FT                                /FTId=VAR_013342.
FT   VARIANT     116    116       G -> R (in ALD; CALD-type;
FT                                dbSNP:rs398123110).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_000030.
FT   VARIANT     138    141       Missing (in ALD; ALD-type).
FT                                /FTId=VAR_000032.
FT   VARIANT     139    139       Missing (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067239.
FT   VARIANT     141    141       A -> T (in ALD; dbSNP:rs193922097).
FT                                /FTId=VAR_000033.
FT   VARIANT     143    143       P -> S (in ALD).
FT                                {ECO:0000269|PubMed:10369742,
FT                                ECO:0000269|PubMed:10480364}.
FT                                /FTId=VAR_009354.
FT   VARIANT     148    148       N -> S (in ALD; ADO-type;
FT                                dbSNP:rs128624216).
FT                                {ECO:0000269|PubMed:10480364,
FT                                ECO:0000269|PubMed:7849723}.
FT                                /FTId=VAR_000034.
FT   VARIANT     149    149       S -> N (in ALD).
FT                                /FTId=VAR_000035.
FT   VARIANT     152    152       R -> C (in ALD; ADO-type).
FT                                {ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_000036.
FT   VARIANT     152    152       R -> L (in ALD).
FT                                /FTId=VAR_009355.
FT   VARIANT     152    152       R -> P (in ALD).
FT                                /FTId=VAR_000037.
FT   VARIANT     152    152       R -> S (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009356.
FT   VARIANT     161    161       S -> P (in ALD).
FT                                /FTId=VAR_009357.
FT   VARIANT     163    163       R -> H (in ALD).
FT                                /FTId=VAR_000038.
FT   VARIANT     163    163       R -> P (in ALD).
FT                                /FTId=VAR_009358.
FT   VARIANT     174    174       Y -> C (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009359.
FT   VARIANT     174    174       Y -> D (in ALD; ALD-type;
FT                                dbSNP:rs128624217).
FT                                {ECO:0000269|PubMed:7849723,
FT                                ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000039.
FT   VARIANT     174    174       Y -> S (in ALD; CALD-type).
FT                                /FTId=VAR_000040.
FT   VARIANT     178    178       Q -> E (in ALD; AMN-type).
FT                                {ECO:0000269|PubMed:7717396}.
FT                                /FTId=VAR_000041.
FT   VARIANT     181    181       Y -> C (in ALD; ALMD-type).
FT                                {ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_000042.
FT   VARIANT     182    182       R -> P (in ALD).
FT                                /FTId=VAR_000043.
FT   VARIANT     189    189       R -> W (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009360.
FT   VARIANT     190    190       L -> P (in ALD).
FT                                {ECO:0000269|PubMed:10480364}.
FT                                /FTId=VAR_009361.
FT   VARIANT     194    194       D -> H (in ALD).
FT                                /FTId=VAR_000044.
FT   VARIANT     198    198       T -> K (in ALD).
FT                                /FTId=VAR_009362.
FT   VARIANT     198    198       T -> R (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067240.
FT   VARIANT     200    200       D -> N (in ALD).
FT                                /FTId=VAR_009363.
FT   VARIANT     200    200       D -> V (in ALD; CALD-type).
FT                                /FTId=VAR_000045.
FT   VARIANT     207    207       S -> SAAS (in ALD).
FT                                /FTId=VAR_013343.
FT   VARIANT     211    211       L -> P (in ALD).
FT                                /FTId=VAR_000046.
FT   VARIANT     213    213       S -> C (in ALD).
FT                                /FTId=VAR_009364.
FT   VARIANT     214    214       N -> D (in ALD).
FT                                /FTId=VAR_009365.
FT   VARIANT     217    217       K -> E (in ALD).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_013344.
FT   VARIANT     218    218       P -> T (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009366.
FT   VARIANT     220    220       L -> P (in ALD).
FT                                /FTId=VAR_000047.
FT   VARIANT     221    221       D -> G (in ALD; CALD and AMN-types).
FT                                /FTId=VAR_000048.
FT   VARIANT     224    224       V -> E (in ALD).
FT                                /FTId=VAR_013345.
FT   VARIANT     229    229       L -> P (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009367.
FT   VARIANT     254    254       T -> M (in ALD; AMN-type).
FT                                {ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000049.
FT   VARIANT     254    254       T -> P (in ALD; AMN-type).
FT                                /FTId=VAR_000050.
FT   VARIANT     263    263       P -> L (in ALD; CALD, AMN and AD-types).
FT                                /FTId=VAR_000051.
FT   VARIANT     266    266       G -> E (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067241.
FT   VARIANT     266    266       G -> R (in ALD; dbSNP:rs128624218).
FT                                {ECO:0000269|PubMed:21700483,
FT                                ECO:0000269|PubMed:7849723}.
FT                                /FTId=VAR_000052.
FT   VARIANT     271    271       E -> K (in ALD).
FT                                /FTId=VAR_009368.
FT   VARIANT     274    274       R -> W (in ALD; dbSNP:rs782760033).
FT                                /FTId=VAR_013346.
FT   VARIANT     276    276       K -> E (in ALD; CALD-type).
FT                                /FTId=VAR_000053.
FT   VARIANT     277    277       G -> GN (in ALD; ADO-type).
FT                                /FTId=VAR_000055.
FT   VARIANT     277    277       G -> R (in ALD; AMN-type).
FT                                /FTId=VAR_000054.
FT   VARIANT     277    277       G -> W (in ALD).
FT                                /FTId=VAR_000056.
FT   VARIANT     280    280       R -> C (in ALD; dbSNP:rs193922098).
FT                                /FTId=VAR_013347.
FT   VARIANT     285    285       R -> P (in ALD).
FT                                /FTId=VAR_009369.
FT   VARIANT     291    291       E -> D (in ALD; ACALD and CALD-types).
FT                                /FTId=VAR_000057.
FT   VARIANT     291    291       E -> K (in ALD; dbSNP:rs128624213).
FT                                {ECO:0000269|PubMed:7904210}.
FT                                /FTId=VAR_000058.
FT   VARIANT     291    291       Missing (in ALD; ALD-type).
FT                                /FTId=VAR_000059.
FT   VARIANT     294    294       A -> T (in ALD; AMN-type).
FT                                /FTId=VAR_000060.
FT   VARIANT     296    296       Y -> C (in ALD; dbSNP:rs797044610).
FT                                /FTId=VAR_009370.
FT   VARIANT     298    298       G -> D (in ALD).
FT                                {ECO:0000269|PubMed:10480364,
FT                                ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009371.
FT   VARIANT     300    300       E -> EVGQ (in ALD).
FT                                {ECO:0000269|PubMed:11810273}.
FT                                /FTId=VAR_013348.
FT   VARIANT     302    302       E -> K (in ALD).
FT                                /FTId=VAR_009372.
FT   VARIANT     316    316       Q -> P (in ALD).
FT                                {ECO:0000269|PubMed:26686776}.
FT                                /FTId=VAR_075285.
FT   VARIANT     322    322       L -> P (in ALD).
FT                                /FTId=VAR_009373.
FT   VARIANT     336    336       K -> M (in ALD).
FT                                /FTId=VAR_009374.
FT   VARIANT     339    339       W -> R (in ALD).
FT                                /FTId=VAR_013349.
FT   VARIANT     342    342       S -> P (in ALD; AMN-type).
FT                                /FTId=VAR_000061.
FT   VARIANT     343    343       G -> D (in ALD).
FT                                /FTId=VAR_013350.
FT   VARIANT     343    343       G -> S (in ALD).
FT                                {ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_023005.
FT   VARIANT     389    389       R -> G (in ALD; AMN-type;
FT                                dbSNP:rs128624215).
FT                                {ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000062.
FT   VARIANT     389    389       R -> H (in ALD; does not affect protein
FT                                stability, homo- and heterodimerization
FT                                with ALDR and PMP70).
FT                                {ECO:0000269|PubMed:10551832}.
FT                                /FTId=VAR_000063.
FT   VARIANT     401    401       R -> Q (in ALD; ALD and AMN-types; does
FT                                not affect protein stability, homo- and
FT                                heterodimerization with ALDR and PMP70;
FT                                dbSNP:rs128624219).
FT                                {ECO:0000269|PubMed:10551832,
FT                                ECO:0000269|PubMed:10737980,
FT                                ECO:0000269|PubMed:10980539,
FT                                ECO:0000269|PubMed:21889498,
FT                                ECO:0000269|PubMed:7849723,
FT                                ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000064.
FT   VARIANT     401    401       R -> W (in ALD).
FT                                {ECO:0000269|PubMed:10737980,
FT                                ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_009375.
FT   VARIANT     418    418       R -> W (in ALD; AMN-type;
FT                                dbSNP:rs128624220).
FT                                {ECO:0000269|PubMed:10737980,
FT                                ECO:0000269|PubMed:10980539,
FT                                ECO:0000269|PubMed:7849723,
FT                                ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000065.
FT   VARIANT     427    427       Missing (in ALD).
FT                                /FTId=VAR_013351.
FT   VARIANT     484    484       P -> R (in ALD; CALD, AMN and ADO-types;
FT                                significantly decreases homodimerization
FT                                and abolishes heterodimerization with
FT                                ALDR and PMP70; dbSNP:rs128624214).
FT                                {ECO:0000269|PubMed:10551832}.
FT                                /FTId=VAR_000066.
FT   VARIANT     503    503       L -> P (in ALD).
FT                                {ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_023006.
FT   VARIANT     507    507       G -> V (in ALD; CALD-types).
FT                                /FTId=VAR_000067.
FT   VARIANT     512    512       G -> S (in ALD; CALD and AS-types;
FT                                reduced ATPase activity).
FT                                {ECO:0000269|PubMed:11248239}.
FT                                /FTId=VAR_000068.
FT   VARIANT     514    514       S -> R (in ALD).
FT                                {ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_023007.
FT   VARIANT     515    515       S -> F (in ALD; dbSNP:rs128624223).
FT                                {ECO:0000269|PubMed:7849723}.
FT                                /FTId=VAR_000069.
FT   VARIANT     516    516       L -> P (in ALD).
FT                                {ECO:0000269|PubMed:21889498}.
FT                                /FTId=VAR_067328.
FT   VARIANT     518    518       R -> Q (in ALD; CALD-type;
FT                                dbSNP:rs398123102).
FT                                {ECO:0000269|PubMed:11438993,
FT                                ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_000070.
FT   VARIANT     518    518       R -> W (in ALD; CALD-type;
FT                                dbSNP:rs128624224).
FT                                {ECO:0000269|PubMed:8040304}.
FT                                /FTId=VAR_000071.
FT   VARIANT     522    522       G -> W (in ALD; AD-type).
FT                                /FTId=VAR_000072.
FT   VARIANT     523    523       L -> F (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067242.
FT   VARIANT     528    528       Missing (in ALD; CALD-type).
FT                                {ECO:0000269|PubMed:7717396}.
FT                                /FTId=VAR_000073.
FT   VARIANT     529    529       G -> S (in ALD).
FT                                {ECO:0000269|PubMed:10480364}.
FT                                /FTId=VAR_009376.
FT   VARIANT     534    534       P -> L (in ALD; CALD-type).
FT                                /FTId=VAR_000074.
FT   VARIANT     540    540       F -> C (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067243.
FT   VARIANT     540    540       F -> S (in ALD).
FT                                /FTId=VAR_009377.
FT   VARIANT     543    543       P -> L (in ALD).
FT                                {ECO:0000269|PubMed:10737980,
FT                                ECO:0000269|PubMed:10980539}.
FT                                /FTId=VAR_009378.
FT   VARIANT     544    544       Q -> R (in ALD).
FT                                /FTId=VAR_009379.
FT   VARIANT     552    552       S -> P (in ALD).
FT                                /FTId=VAR_009380.
FT   VARIANT     554    554       R -> H (in ALD; dbSNP:rs201568579).
FT                                {ECO:0000269|PubMed:10737980,
FT                                ECO:0000269|PubMed:15643618}.
FT                                /FTId=VAR_009381.
FT   VARIANT     556    556       Q -> R (in ALD; ACALD type).
FT                                {ECO:0000269|PubMed:10980539}.
FT                                /FTId=VAR_013352.
FT   VARIANT     560    560       P -> L (in ALD; CALD-type;
FT                                dbSNP:rs398123105).
FT                                {ECO:0000269|PubMed:21700483,
FT                                ECO:0000269|PubMed:21889498,
FT                                ECO:0000269|PubMed:7717396}.
FT                                /FTId=VAR_000075.
FT   VARIANT     560    560       P -> R (in ALD; AMN and ALMD-types).
FT                                /FTId=VAR_000076.
FT   VARIANT     560    560       P -> S (in ALD).
FT                                /FTId=VAR_013353.
FT   VARIANT     566    566       M -> K (in ALD).
FT                                /FTId=VAR_000077.
FT   VARIANT     591    591       R -> P (in ALD).
FT                                /FTId=VAR_013354.
FT   VARIANT     591    591       R -> Q (in ALD; AMN-type; significantly
FT                                decreases homodimerization and abolishes
FT                                heterodimerization with ALDR and PMP70).
FT                                {ECO:0000269|PubMed:10551832}.
FT                                /FTId=VAR_000078.
FT   VARIANT     591    591       R -> W (in ALD; dbSNP:rs398123106).
FT                                /FTId=VAR_009382.
FT   VARIANT     606    606       S -> L (in ALD; decreased ATP-binding
FT                                affinity; dbSNP:rs128624225).
FT                                {ECO:0000269|PubMed:11248239,
FT                                ECO:0000269|PubMed:8040304}.
FT                                /FTId=VAR_000079.
FT   VARIANT     606    606       S -> P (in ALD; CALD, AMN and ALMD-types;
FT                                dbSNP:rs201774661).
FT                                {ECO:0000269|PubMed:21700483,
FT                                ECO:0000269|PubMed:21889498}.
FT                                /FTId=VAR_000080.
FT   VARIANT     608    608       G -> D (in ALD; CALD-type;
FT                                dbSNP:rs78993751).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_013355.
FT   VARIANT     609    609       E -> G (in ALD).
FT                                /FTId=VAR_000081.
FT   VARIANT     609    609       E -> K (in ALD; AMN-type;
FT                                dbSNP:rs150346282).
FT                                {ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000082.
FT   VARIANT     616    616       A -> V (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009383.
FT   VARIANT     617    617       R -> C (in ALD; ALD-type and
FT                                asymptomatic; dbSNP:rs4010613).
FT                                {ECO:0000269|PubMed:8040304,
FT                                ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000083.
FT   VARIANT     617    617       R -> G (in ALD; ADO and AMN-types with
FT                                cerebral involvement).
FT                                {ECO:0000269|PubMed:8566952}.
FT                                /FTId=VAR_000084.
FT   VARIANT     617    617       R -> H (in ALD; dbSNP:rs11146842).
FT                                {ECO:0000269|PubMed:21700483,
FT                                ECO:0000269|PubMed:8040304}.
FT                                /FTId=VAR_000085.
FT   VARIANT     626    626       A -> D (in ALD).
FT                                /FTId=VAR_013356.
FT   VARIANT     626    626       A -> T (in ALD; CALD and AMN-types).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_000086.
FT   VARIANT     629    629       D -> H (in ALD).
FT                                /FTId=VAR_000087.
FT   VARIANT     630    630       E -> G (in ALD).
FT                                /FTId=VAR_009384.
FT   VARIANT     631    631       C -> Y (in ALD).
FT                                /FTId=VAR_009385.
FT   VARIANT     632    632       T -> I (in ALD).
FT                                /FTId=VAR_013357.
FT   VARIANT     632    632       T -> P (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067244.
FT   VARIANT     633    633       S -> I (in ALD; asymptomatic).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_013358.
FT   VARIANT     633    633       S -> R (in ALD).
FT                                {ECO:0000269|PubMed:10737980,
FT                                ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_009386.
FT   VARIANT     635    635       V -> M (in ALD; dbSNP:rs201427153).
FT                                /FTId=VAR_013359.
FT   VARIANT     636    636       S -> I (in ALD).
FT                                /FTId=VAR_009387.
FT   VARIANT     638    638       D -> Y (in ALD).
FT                                {ECO:0000269|PubMed:10480364}.
FT                                /FTId=VAR_009388.
FT   VARIANT     640    640       E -> K (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067245.
FT   VARIANT     646    646       A -> P (in ALD).
FT                                {ECO:0000269|PubMed:10737980}.
FT                                /FTId=VAR_009389.
FT   VARIANT     654    654       L -> P (in ALD).
FT                                /FTId=VAR_009390.
FT   VARIANT     657    657       Missing (in ALD; CALD-type).
FT                                /FTId=VAR_000088.
FT   VARIANT     660    660       R -> P (in ALD; CALD-type).
FT                                {ECO:0000269|PubMed:11438993}.
FT                                /FTId=VAR_013360.
FT   VARIANT     660    660       R -> Q (in ALD).
FT                                {ECO:0000269|PubMed:21889498}.
FT                                /FTId=VAR_067329.
FT   VARIANT     660    660       R -> W (in ALD; CALD, ALMD and AS-types).
FT                                /FTId=VAR_000089.
FT   VARIANT     667    667       H -> D (in ALD).
FT                                /FTId=VAR_009391.
FT   VARIANT     668    668       T -> I (in ALD).
FT                                /FTId=VAR_009392.
FT   VARIANT     677    677       G -> D (in ALD).
FT                                {ECO:0000269|PubMed:21700483}.
FT                                /FTId=VAR_067246.
FT   VARIANT     679    679       W -> R (in ALD; AMN-type).
FT                                {ECO:0000269|PubMed:9452087}.
FT                                /FTId=VAR_000090.
FT   VARIANT     693    693       T -> M (in ALD; dbSNP:rs782311214).
FT                                /FTId=VAR_009393.
FT   CONFLICT    123    123       V -> A (in Ref. 1; CAA79922/CAA83230).
FT                                {ECO:0000305}.
SQ   SEQUENCE   745 AA;  82937 MW;  82F90905F71FFDC8 CRC64;
     MPVLSRPRPW RGNTLKRTAV LLALAAYGAH KVYPLVRQCL APARGLQAPA GEPTQEASGV
     AAAKAGMNRV FLQRLLWLLR LLFPRVLCRE TGLLALHSAA LVSRTFLSVY VARLDGRLAR
     CIVRKDPRAF GWQLLQWLLI ALPATFVNSA IRYLEGQLAL SFRSRLVAHA YRLYFSQQTY
     YRVSNMDGRL RNPDQSLTED VVAFAASVAH LYSNLTKPLL DVAVTSYTLL RAARSRGAGT
     AWPSAIAGLV VFLTANVLRA FSPKFGELVA EEARRKGELR YMHSRVVANS EEIAFYGGHE
     VELALLQRSY QDLASQINLI LLERLWYVML EQFLMKYVWS ASGLLMVAVP IITATGYSES
     DAEAVKKAAL EKKEEELVSE RTEAFTIARN LLTAAADAIE RIMSSYKEVT ELAGYTARVH
     EMFQVFEDVQ RCHFKRPREL EDAQAGSGTI GRSGVRVEGP LKIRGQVVDV EQGIICENIP
     IVTPSGEVVV ASLNIRVEEG MHLLITGPNG CGKSSLFRIL GGLWPTYGGV LYKPPPQRMF
     YIPQRPYMSV GSLRDQVIYP DSVEDMQRKG YSEQDLEAIL DVVHLHHILQ REGGWEAMCD
     WKDVLSGGEK QRIGMARMFY HRPKYALLDE CTSAVSIDVE GKIFQAAKDA GIALLSITHR
     PSLWKYHTHL LQFDGEGGWK FEKLDSAARL SLTEEKQRLE QQLAGIPKMQ RRLQELCQIL
     GEAVAPAHVP APSPQGPGGL QGAST
//
